drugset / Trial / NCT03024684
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment
Phase 4
Active not recruiting
240 enrolled
Chiayi Christian Hospital
Chi Mei Medical Hospital · collabE-DA Hospital · collabMackay Memorial Hospital · collabNational Cheng-Kung University Hospital · collabNational Taiwan University Hospital · collabTaichung Veterans General Hospital · collabTainan Municipal Hospital · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate whether statin could prevent recurrence of hepatocellular carcinoma after curative treatment
Timeline
- Start
- 2017-01-03
- Primary completion
- 2025-01
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 10 mg | Oral |